107 related articles for article (PubMed ID: 9572663)
1. Haemolytic uraemic syndrome associated with bleomycin, epirubicin and cisplatin chemotherapy--a case report and review of the literature.
van der Heijden M; Ackland SP; Deveridge S
Acta Oncol; 1998; 37(1):107-9. PubMed ID: 9572663
[No Abstract] [Full Text] [Related]
2. Chemotherapy-related hemolytic-uremic syndrome following treatment of a carcinoma of the nasopharynx.
Thurnher D; Kletzmayr J; Formanek M; Quint C; Czerny C; Burian M; Kornek G
Oncology; 2001; 61(2):143-6. PubMed ID: 11528253
[TBL] [Abstract][Full Text] [Related]
3. [Tumor lysis syndrome with symptomatic hyperuricemia after a first chemotherapeutic treatment of undifferentiated carcinoma of the cavum].
Penel N; Kouto H; Ala-Eddine C; Degardin M
Rev Med Interne; 2002 Mar; 23(3):337-9. PubMed ID: 11928386
[No Abstract] [Full Text] [Related]
4. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin, and cisplatin for patients with locally advanced, metastatic, or recurrent undifferentiated carcinoma of the nasopharyngeal type.
Taamma A; Fandi A; Azli N; Wibault P; Chouaki N; Hasbini A; Couteau C; Armand JP; Cvitkovic E
Cancer; 1999 Oct; 86(7):1101-8. PubMed ID: 10506692
[TBL] [Abstract][Full Text] [Related]
6. Hemolytic uremic syndrome following cisplatin, bleomycin, and vincristine chemotherapy: a report of a case and a review of the literature.
Gardner G; Mesler D; Gitelman HJ
Ren Fail; 1989; 11(2-3):133-7. PubMed ID: 2482985
[TBL] [Abstract][Full Text] [Related]
7. Hemolytic-uremic syndrome associated with neoadjuvant chemotherapy in the treatment of advanced cervical cancer.
Angiola G; Bloss JD; DiSaia PJ; Warner AS; Manetta A; Berman ML
Gynecol Oncol; 1990 Nov; 39(2):214-7. PubMed ID: 1699855
[TBL] [Abstract][Full Text] [Related]
8. Haemolytic uraemic syndrome following chemotherapy for an unusual germ-cell tumour.
Mathur RV; Kumar S; Aparicio S; Johnson PW; Newstead CG
Nephrol Dial Transplant; 1999 Jul; 14(7):1786-8. PubMed ID: 10435899
[No Abstract] [Full Text] [Related]
9. The standard to come: systemic therapies for systemic disease.
Vokes EE; Liebowitz D
Cancer J Sci Am; 1995; 1(3):184-6. PubMed ID: 9166473
[No Abstract] [Full Text] [Related]
10. Haemolytic uraemic syndrome associated with gemcitabine.
Moya-Horno I; Querol Niñerola R; Bonfill Abella T; Dalmau Pórtulas E; Gallardo-Díaz E; Saigí Grau E; Pericay Pijaume C
Clin Transl Oncol; 2010 May; 12(5):381-3. PubMed ID: 20466623
[TBL] [Abstract][Full Text] [Related]
11. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival.
;
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):463-9. PubMed ID: 8655368
[TBL] [Abstract][Full Text] [Related]
12. High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin, and cisplatin before radiotherapy.
Bachouchi M; Cvitkovic E; Azli N; Gasmi J; Cortes-Funes H; Boussen H; Rahal M; Kalifa C; Schwaab G; Eschwege F
J Natl Cancer Inst; 1990 Apr; 82(7):616-20. PubMed ID: 1690306
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy.
Jackson AM; Rose BD; Graff LG; Jacobs JB; Schwartz JH; Strauss GM; Yang JP; Rudnick MR; Elfenbein IB; Narins RG
Ann Intern Med; 1984 Jul; 101(1):41-4. PubMed ID: 6203452
[TBL] [Abstract][Full Text] [Related]
14. Haemolytic uraemic syndrome in a patient with lung cancer: further evidence for a toxic interaction between mitomycin-C and tamoxifen.
Ellis PA; Luckitt J; Treleaven J; Smith IE
Clin Oncol (R Coll Radiol); 1996; 8(6):402-3. PubMed ID: 8973862
[No Abstract] [Full Text] [Related]
15. [Magnesium deficiency caused by epirubicin/cisplatin].
Lechner W; Söldner E; Sachsenmaier M; Philadelphy H; Jarosch E
Zentralbl Gynakol; 1989; 111(21):1438-40. PubMed ID: 2603585
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin-associated hemolytic-uremic syndrome. Successful treatment with a staphylococcal protein A column.
Watson PR; Guthrie TH; Caruana RJ
Cancer; 1989 Oct; 64(7):1400-3. PubMed ID: 2528403
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N
ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312
[TBL] [Abstract][Full Text] [Related]
18. Case report: cisplatin-induced hemolytic uremic syndrome.
Khansur T; Kennedy A
Am J Med Sci; 1991 Jun; 301(6):390-2. PubMed ID: 1645502
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic hypocalcemia and hypomagnesiemia in cisplatinum-based chemotherapy treated patients: case report.
Maina A; Richiardi G; Danese S; Defabiani E; Giardina G
Eur J Gynaecol Oncol; 1996; 17(4):281-2. PubMed ID: 8856305
[No Abstract] [Full Text] [Related]
20. [Combined (chemo-radiation) treatment of patients with nasopharyngeal cancer].
Seriakov AP; Kopychev IuE; Gorbunov VA; Zav'ialov MS; Kubyshkin SI; Smolin AV; Sukirko VA
Voen Med Zh; 2005 Nov; 326(11):38-43, 111. PubMed ID: 16404906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
